STAAR Surgical Debt to Equity Ratio 2010-2024 | STAA

Current and historical debt to equity ratio values for STAAR Surgical (STAA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. STAAR Surgical debt/equity for the three months ending September 30, 2024 was 0.00.
STAAR Surgical Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $0.11B $0.43B 0.26
2024-06-30 $0.10B $0.41B 0.25
2024-03-31 $0.10B $0.39B 0.25
2023-12-31 $0.10B $0.39B 0.27
2023-09-30 $0.09B $0.38B 0.25
2023-06-30 $0.09B $0.35B 0.25
2023-03-31 $0.08B $0.34B 0.24
2022-12-31 $0.08B $0.34B 0.25
2022-09-30 $0.08B $0.32B 0.23
2022-06-30 $0.08B $0.30B 0.26
2022-03-31 $0.08B $0.28B 0.27
2021-12-31 $0.09B $0.26B 0.34
2021-09-30 $0.08B $0.25B 0.30
2021-06-30 $0.06B $0.24B 0.26
2021-03-31 $0.05B $0.21B 0.24
2020-12-31 $0.06B $0.20B 0.31
2020-09-30 $0.05B $0.19B 0.26
2020-06-30 $0.04B $0.18B 0.25
2020-03-31 $0.04B $0.17B 0.25
2019-12-31 $0.05B $0.16B 0.30
2019-09-30 $0.04B $0.15B 0.29
2019-06-30 $0.04B $0.14B 0.29
2019-03-31 $0.04B $0.14B 0.29
2018-12-31 $0.04B $0.13B 0.26
2018-09-30 $0.03B $0.13B 0.27
2018-06-30 $0.03B $0.05B 0.62
2018-03-31 $0.03B $0.05B 0.71
2017-12-31 $0.03B $0.04B 0.58
2017-09-30 $0.03B $0.04B 0.79
2017-06-30 $0.03B $0.04B 0.66
2017-03-31 $0.03B $0.04B 0.77
2016-12-31 $0.03B $0.04B 0.73
2016-09-30 $0.03B $0.04B 0.76
2016-06-30 $0.03B $0.04B 0.72
2016-03-31 $0.02B $0.04B 0.61
2015-12-31 $0.02B $0.04B 0.62
2015-09-30 $0.02B $0.04B 0.57
2015-06-30 $0.02B $0.04B 0.52
2015-03-31 $0.02B $0.04B 0.56
2014-12-31 $0.02B $0.04B 0.59
2014-09-30 $0.02B $0.04B 0.55
2014-06-30 $0.02B $0.04B 0.54
2014-03-31 $0.02B $0.04B 0.56
2013-12-31 $0.02B $0.04B 0.59
2013-09-30 $0.02B $0.04B 0.57
2013-06-30 $0.02B $0.04B 0.58
2013-03-31 $0.02B $0.03B 0.61
2012-12-31 $0.02B $0.03B 0.73
2012-09-30 $0.02B $0.03B 0.59
2012-06-30 $0.02B $0.03B 0.58
2012-03-31 $0.02B $0.03B 0.58
2011-12-31 $0.02B $0.03B 0.66
2011-09-30 $0.02B $0.03B 0.62
2011-06-30 $0.02B $0.03B 0.67
2011-03-31 $0.02B $0.02B 0.72
2010-12-31 $0.02B $0.02B 0.81
2010-09-30 $0.02B $0.02B 0.78
2010-06-30 $0.02B $0.02B 0.72
2010-03-31 $0.03B $0.02B 1.41
2009-12-31 $0.04B $0.02B 1.79
2009-09-30 $0.04B $0.02B 1.64
2009-06-30 $0.04B $0.02B 1.55
2009-03-31 $0.04B $0.01B 2.46
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.315B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.108B 21.59
Becton Dickinson (BDX) United States $64.746B 17.02
Cardinal Health (CAH) United States $29.487B 15.99
West Pharmaceutical Services (WST) United States $22.928B 46.83
Cooper (COO) United States $20.075B 28.58
Labcorp (LH) United States $20.046B 16.62
Align Technology (ALGN) United States $16.863B 32.27
Henry Schein (HSIC) United States $9.361B 17.83
Merit Medical Systems (MMSI) United States $6.139B 31.35
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
CONMED (CNMD) United States $2.314B 19.31
Patterson (PDCO) United States $1.803B 9.52
Lifevantage (LFVN) United States $0.178B 23.67
Pro-Dex (PDEX) United States $0.152B 30.36